{
    "2021-09-17": [
        [
            {
                "time": "2021-09-17",
                "original_text": "FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations",
                "features": {
                    "keywords": [
                        "FDA",
                        "Advisory",
                        "Committee",
                        "COMIRNATY",
                        "Booster",
                        "Emergency",
                        "Use",
                        "65",
                        "Older",
                        "High-risk"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study",
                "features": {
                    "keywords": [
                        "Astellas",
                        "Pfizer",
                        "XTANDI",
                        "Reduced",
                        "Risk",
                        "Death",
                        "Phase",
                        "ARCHES",
                        "Study"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "FDA Committee Vote Is a Rebuff to Biden. Impact on Vaccine Makers Is Less Clear.",
                "features": {
                    "keywords": [
                        "FDA",
                        "Committee",
                        "Vote",
                        "Rebuff",
                        "Biden",
                        "Vaccine",
                        "Makers"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "Former Mylan executive pleads guilty to insider trading",
                "features": {
                    "keywords": [
                        "Mylan",
                        "executive",
                        "pleads",
                        "guilty",
                        "insider",
                        "trading"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "FDA panel recommends Pfizer’s COVID-19 booster for 65 and older, but not for the general public",
                "features": {
                    "keywords": [
                        "FDA",
                        "panel",
                        "recommends",
                        "Pfizer",
                        "COVID-19",
                        "booster",
                        "65",
                        "older",
                        "general",
                        "public"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "FDA advisory panel authorizes booster dose for those 65 & older",
                "features": {
                    "keywords": [
                        "FDA",
                        "advisory",
                        "panel",
                        "authorizes",
                        "booster",
                        "dose",
                        "65",
                        "older"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "FDA Panel Votes No on Biden’s Booster Shot Plan. Drug Stocks Fall.",
                "features": {
                    "keywords": [
                        "FDA",
                        "Panel",
                        "Votes",
                        "No",
                        "Biden",
                        "Booster",
                        "Shot",
                        "Plan",
                        "Drug",
                        "Stocks",
                        "Fall"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government",
                        "stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "BioNTech, Moderna Stocks Crumble As FDA Advisors Vote Down Broad Covid Boosters",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "Moderna",
                        "Stocks",
                        "Crumble",
                        "FDA",
                        "Advisors",
                        "Vote",
                        "Down",
                        "Broad",
                        "Covid",
                        "Boosters"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "FDA advisory panel votes against approving COVID-19 booster",
                "features": {
                    "keywords": [
                        "FDA",
                        "advisory",
                        "panel",
                        "votes",
                        "against",
                        "approving",
                        "COVID-19",
                        "booster"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-17",
                "original_text": "FDA panel votes for Pfizer's booster shot for high risk, ages 65+",
                "features": {
                    "keywords": [
                        "FDA",
                        "panel",
                        "votes",
                        "Pfizer",
                        "booster",
                        "shot",
                        "high",
                        "risk",
                        "ages",
                        "65+"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}